Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Breaking News
Food truck hit by gunfire in Raleigh
Program
It's time for football! Tune to WRAL-TV to catch all the Week 1 highlights on Football Friday
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
15.94
+0.26 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
2 Growth Stocks I'd Buy on the Dip
September 30, 2023
These two growth stocks could be worthwhile buy-and-holds.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Analyst Ratings for ACADIA Pharmaceuticals
August 22, 2023
Via
Benzinga
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?
August 22, 2023
This biotech stock has been on fire in 2023.
Via
The Motley Fool
Analyst Expectations for ACADIA Pharmaceuticals's Future
August 03, 2023
Via
Benzinga
ACADIA Pharmaceuticals's Earnings: A Preview
August 01, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications
September 19, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Why Acadia Pharmaceuticals Stock Is Soaring Today
July 14, 2023
Investors are cheering Acadia's latest news.
Via
The Motley Fool
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
August 30, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
2 Supercharged Growth Stocks Billionaires Can't Stop Buying
August 28, 2023
A top hedge fund has been steadily buying these two growth stocks in 2023.
Via
The Motley Fool
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 14, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
August 07, 2023
Via
Benzinga
Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview
August 02, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer
July 24, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023
July 19, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves
July 18, 2023
Acadia may experience a profit-taking pullback near-term but the recent high volume gapper and promising pipeline developments bode well for long-term uptrend.
Via
MarketBeat
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
July 14, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P...
Via
Benzinga
Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
July 14, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also...
Via
Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Via
Benzinga
Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High
July 14, 2023
The company also expanded its commercial rights to the drug and added another to its line-up.
Via
Investor's Business Daily
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Are Acadia Pharmaceuticals Shares Trading Higher Today?
July 14, 2023
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher after the company expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday
July 14, 2023
Keybanc boosted the price target for Spotify Technology S.A. (NYSE: SPOT) from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.